Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1978-09-01
1980-02-26
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424331, A61K 3112, A61K 31195
Patent
active
041906721
ABSTRACT:
Improved methods are provided for the treatment of the central nervous system dopamine-deficiency diseases (CNS-DADD's), including Parkinson's disease and other parkinsonisms, which comprises the administration of 3',4'-dihydroxy-2-methyl-isopropiophenone (DHMPP) in an amount effective to inhibit the conversion of levodopa to 3-O-methyldopa (OMD) by catechol-O-methyl transferase (COMT). The present method results in a reduction of the dosage of levodopa otherwise required to symptomatically control the CNS-DADD, providing a concomitant reduction in the untoward side effects of levodopa administration. Also provided are novel pharmaceutical compositions of levodopa and DHMPP.
REFERENCES:
patent: 2929848 (1960-03-01), Woodruff et al.
patent: 3790674 (1974-02-01), Rodriguez
patent: 3984545 (1976-10-01), Fril, Jr. et al.
patent: 3991207 (1976-11-01), Sarges et al.
Chem. Abst., vol. 67-8134a (1967).
Armitage Robert A.
Friedman Stanley J.
LandOfFree
Method and compositions of treating Parkinsonisms with levodopa does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and compositions of treating Parkinsonisms with levodopa , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and compositions of treating Parkinsonisms with levodopa will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2113484